Predictive Oncology (NASDAQ:AGPU – Get Free Report) released its quarterly earnings results on Friday. The company reported ($0.36) EPS for the quarter, FiscalAI reports. The business had revenue of $0.04 million during the quarter.
Predictive Oncology Price Performance
AGPU stock opened at $5.85 on Friday. Predictive Oncology has a fifty-two week low of $1.03 and a fifty-two week high of $32.10. The stock’s 50 day moving average price is $3.86. The stock has a market cap of $32.41 million, a P/E ratio of -0.46 and a beta of 3.45.
Analysts Set New Price Targets
A number of research analysts have commented on the company. Wall Street Zen lowered Predictive Oncology to a “strong sell” rating in a research report on Saturday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Predictive Oncology in a report on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Predictive Oncology currently has an average rating of “Sell”.
Predictive Oncology Company Profile
Predictive Oncology (NASDAQ: AGPU) is a biotechnology company focused on oncology-related research and product development that combines laboratory science with data analytics. The company positions itself to support precision medicine by applying computational methods and laboratory testing to better understand tumor biology and to accelerate the identification and development of oncology therapeutics and diagnostics.
Its activities include laboratory-based testing and analytic services intended to inform drug discovery and development, biomarker identification, and patient stratification efforts.
Recommended Stories
- Five stocks we like better than Predictive Oncology
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
- MarketBeat Week in Review – 05/11 – 05/15
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
